The impact of NGOs around the world is increasing every year. Activists are gaining more and more public support, and their projects are already being implemented at the global level. There is no surprise that NGO financial demands are increasing accordingly.

Each year we commemorate World TB Day on March 24 to raise public awareness about the devastating health, social and economic consequences of tuberculosis (TB) and to step up efforts to end the global TB epidemic. The date marks the day in 1882 when Dr. ...

We are pleased to announce the strong and diverse plenary programme speaker line-up for the 22nd International AIDS Conference (AIDS 2018). Plenary sessions bring all conference delegates together at the first session of every morning. Register for AIDS 2018 and join some of the world's ...

Continuing many years constructive collaboration, Dr Zsuzsanna Jakab, WHO Regional Director for Europe and Dr Svetlana Cebotari, Minister of Health, Labour and Social Protection signed the Biennial Collaborative Agreement (BCA) between WHO/Europe and the Republic of Moldova for 2018–2019 on 20 February 2018. The signing ...

The rapid growth of the HIV/AIDS epidemic in the EECA countries, along with the shrinking donor funding and, at the same time, continuous advocacy for access to treatment by representatives of key communities serves as an incentive for seeking new sources of sustainable support for ...

The #YouAreNotAlone campaign is raising awareness about the stigma and discrimination faced by children, adolescents and families affected by HIV in eastern Europe and central Asia.

The AIDS 2018 pre-conference programme will take place at the RAI Amsterdam Convention Centre on Saturday, 21 July, and Sunday, 22 July.

A new campaign highlights the health issues that can affect us as we get older - and which HIV positive people need to be aware about

The INCB Annual Report, prepared in accordance with the international drug control treaties, examines the global drug control situation, and makes recommendations to Governments and regional and international organizations. The thematic chapter of the INCB Annual Report for 2017 focuses on treatment, rehabilitation and social reintegration ...

Belarus made a big step forward in combating discrimination against people living with HIV. Viney Saldana, UNAIDS Regional Director for Eastern Europe & Central Asia, stated this at a special joint event dedicated to the Zero Discrimination Day.

Partners of the East Europe and Central Asia Union of People Living with HIV (ECUO) held a meeting in Kyiv with the support of the UNAIDS regional office in Eastern Europe and Central Asia.

Based on the results of the strategic planning, a strategic plan of activities for 2018-2021 will be developed, and members, employees, volunteers and partners of the organization will be able to have a consolidated updated vision and understanding of the organization's mission and activities in ...

This new document – the guide to develop a national TB PPM action plan – is a planning document designed to facilitate the integration of strong PPM components into national TB strategic plans that are supposed to be the basis for Global Fund proposals and ...

Therapies to prevent infection are advancing in a crowded field.

If a person takes efficient antiretroviral therapy, HIV infection is not sexually transmitted - this statement, published on January 30, 2008 in the Swiss medical newspaper, has become really groundbreaking news and has entered medical history as the "Swiss Statement". A modern German study shows that ...

The campaign dedicated to the International Zero Discrimination Day has already started in Kazakhstan. Tomorrow the social media accounts of celebrities and UNAIDS resources will feature videos with stories of adolescents living with HIV in Russia and Armenia. On February 28, at 20.00 Moscow time ...

New study provides insights into the factors that influence HIV treatment adherence in Latin America and the Caribbean. Results show that individuals from lower resource settings often achieve higher levels of adherence, contrary to predictions.

One injection of the cloned antibody significantly reduced participants’ viral load in a recent advanced trial.